As we head toward a post-Canada announcement reality, the bar for future price per share premium is going to rise, and Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF) likely has a frontrunning position given expectations for rising capacity over and above all but a few of the top players in the space. That’s why Aurora sunk all that cash into the company 6 months ago. That said, what it needs is a more developed distribution platform. That’s why we were glad to see the company announce it has received its medical sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations for its Ancaster, Ontario facility.
“As we prepare for our Founders Club product launch in January 2019, this is a critical step in our path to becoming the global leading organic cannabis brand,” said Brian Athaide, CEO of TGOD. “We have been perfecting our organic grow methodology in Ancaster and are prepared for the Q1 launch to medical patients across Canada followed by the launch in adult use markets in Q2.”
Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF) is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis.
The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 116,000 kg and is building 970,000 sq. ft. of cultivation facilities in Ontario and Quebec.
The Company has developed a strategic partnership with Aurora Cannabis Inc. (TSX:ACB) whereby Aurora has invested approximately C$78.1 million for an approximate 17.5% stake in TGOD. In addition, the Company has raised approximately C$290 million dollars and has over 5,000 shareholders. TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.
Find out when $TGODF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, TGODF just announced it has received its medical sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations for its Ancaster, Ontario facility. The stock has been basically flat over the past week. But we have also seen a jump in transaction volume recently, with the past month seeing 79% above its longer-run average levels.
“We have been working aggressively on both productive capacity and global distribution,” said John Wren, VP of Operations at TGOD. “In addition to Ancaster, we are currently growing in Valleyfield, Quebec at our breeding facility, Jamaica with our partner Epican and Poland with HemPoland. We are on track to progressively ramp up our production throughout 2019, targeting 195,000 kgs of run-rate capacity by the end of the year. TGOD is securing significant distribution networks in Canada, Europe, Jamaica, and Latin America while scaling operations for medical and adult use markets around the world,” continued Mr. Wren.
Earning a current market cap value of $1.05B, TGODF has a significant war chest ($261.8M) of cash on the books, which stands against about $14M in total current liabilities. The company is pre-revenue at this point. This is an exciting story, and we look forward to a follow-up chapter as events transpire. Sign-up for continuing coverage on shares of $TGODF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $TGODF, either long or short, and we have not been compensated for this article.